PARP1 has implications not only in cancer but also in neurodegenerative diseases [169]; activation of PARP1 has been linked to PD pathogenesis in a mouse model, and changes in PAR polymers present in cerebrospinal fluid and brain homogenates of PD patients have been reported [170]. The gene discussed is PARP1; the disease is Parkinson disease.